Financial Synergies Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History

Financial Synergies Wealth Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39	Closed	-$1.59K	–	527
2023 Q1	$1.59K	Buy	+39	New	+$1.55K	﹤0.01%	319
2022 Q4	–	Sell	-3	Closed	-$160	–	491
2022 Q3	$160	Hold	3	–	–	﹤0.01%	455
2022 Q2	$175	Buy	+3	New	+$197	﹤0.01%	476

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Financial Synergies Wealth Advisors's PCRX Position: Q2 2023 in Review

Financial Synergies Wealth Advisors sold out of Pacira BioSciences (PCRX) in Q2 2023, closing a stake of 39 shares — an estimated $1.59K sold.

Financial Synergies Wealth Advisors first reported a position in PCRX in Q2 2022 and held it in 3 quarters. The position peaked at $1.59K in Q1 2023. 258 funds tracked by Wall St. Rank hold PCRX as of Q2 2023.

Financial Synergies Wealth Advisors reported no remaining Pacira BioSciences position as of Q2 2023 after selling out during the quarter.
Financial Synergies Wealth Advisors sold 39 Pacira BioSciences shares in Q2 2023, an estimated $1.59K.
Financial Synergies Wealth Advisors first reported a position in Pacira BioSciences in Q2 2022 and held it in 3 quarters.
Financial Synergies Wealth Advisors's Pacira BioSciences position peaked at $1.59K in Q1 2023.
258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2023.

Based on Financial Synergies Wealth Advisors's 13F filing for Q2 2023, filed 4 Apr 2024.